Skip to main content
DAEWON PHARMACEUTICAL CO.,LTD logo

DAEWON PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 003220 ISIN · KR7003220001 KO Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2019-07-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 003220

About DAEWON PHARMACEUTICAL CO.,LTD

https://www.daewonpharm.com/eng

Daewon Pharmaceutical Co., Ltd., established in 1958, is a pharmaceutical company focused on improving human health. The company specializes in the development and manufacturing of prescription drugs and finished pharmaceutical products. Its portfolio includes a range of medications such as antipyretics, analgesics, and treatments for respiratory and cardiovascular conditions. Daewon Pharmaceutical maintains a strong commitment to research and development, with a strategic focus on New Chemical Entities (NCE) and Incrementally Modified Drugs (IMD) to provide advanced healthcare solutions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service of Korea regarding their stake in Daewon Pharmaceutical. This type of filing is a regulatory requirement for institutional investors when their ownership crosses specific thresholds (typically 5% or more). In the provided classification schema, this falls under 'Major Shareholding Notification' (MRQ).
2019-07-03 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Daewon Pharmaceutical Co., Ltd. covering the period from January 1, 2019, to March 31, 2019. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the acquisition of shares by FIL Limited and its special related parties in Daewon Pharmaceutical. This document type is specifically designed to notify the market of significant changes in share ownership, which falls under the 'Major Shareholding Notification' category.
2019-04-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in Daewon Pharmaceutical (대원제약). This is a standard regulatory filing in South Korea used to notify the market when a major shareholder's stake crosses a specific threshold (5% rule). In the provided classification schema, this falls under 'Major Shareholding Notification'.
2019-04-02 Korean
최대주주등소유주식변동신고서(최대주주변경시)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Daewon Pharmaceutical. It details specific share transfers (gifts/donations) between major shareholders and their relatives, including changes in the status of the largest shareholder. This type of filing is a regulatory requirement for disclosing changes in significant share ownership and control, which falls under the 'Major Shareholding Notification' category.
2019-03-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (specifically Baek Seung-ho and related parties) due to gifts and stock acquisitions. This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.